250 related articles for article (PubMed ID: 15526395)
1. Updated guidelines for the use of rifamycins in HIV/TB-coinfected patients.
del Rio C
AIDS Clin Care; 2004 Oct; 16(10):85. PubMed ID: 15526395
[No Abstract] [Full Text] [Related]
2. Resistance in intermittent TB therapy.
Albrecht H
AIDS Clin Care; 2002 May; 14(5):46-7. PubMed ID: 12004879
[No Abstract] [Full Text] [Related]
3. Anti-HIV agents. Once-daily anti-HIV therapy in people co-infected with TB.
TreatmentUpdate; 2004; 16(3):4-5. PubMed ID: 17219607
[No Abstract] [Full Text] [Related]
4. Concurrent ART/TB treatment finally proven to be beneficial.
Ryan CT
AIDS Clin Care; 2008 Nov; 20(11):89. PubMed ID: 19170252
[TBL] [Abstract][Full Text] [Related]
5. "Punctuated" HIV meds planned for TB patients.
AIDS Read; 2001 Jul; 11(7):348, 353. PubMed ID: 11494704
[No Abstract] [Full Text] [Related]
6. Issues in the treatment of active tuberculosis in human immunodeficiency virus-infected patients.
Schluger NW
Clin Infect Dis; 1999 Jan; 28(1):130-5. PubMed ID: 10028083
[TBL] [Abstract][Full Text] [Related]
7. Funding. Experts look for more to fight TB, HIV/AIDS coinfection.
AIDS Policy Law; 2009 Sep; 24(10):3. PubMed ID: 19827208
[No Abstract] [Full Text] [Related]
8. Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Mar; 51(10):214-5. PubMed ID: 11922192
[TBL] [Abstract][Full Text] [Related]
9. Nurse and mother faces her own TB and HIV.
Cullinan K
Bull World Health Organ; 2002; 80(3):260. PubMed ID: 11984618
[No Abstract] [Full Text] [Related]
10. Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Mar; 49(9):185-9. PubMed ID: 11795500
[TBL] [Abstract][Full Text] [Related]
11. Optimum time to start antiretroviral therapy in patients with HIV-associated tuberculosis: before or after tuberculosis diagnosis?
Kerkhoff AD; Wood R; Lawn SD
AIDS; 2011 Apr; 25(7):1003-6. PubMed ID: 21346513
[TBL] [Abstract][Full Text] [Related]
12. Tuberculosis in people with HIV.
Bellamy R
Clin Evid; 2005 Dec; (14):858-68. PubMed ID: 16620440
[No Abstract] [Full Text] [Related]
13. Playing god in Kathmandu.
Kafle R
GMHC Treat Issues; 2005; 19(5-6):15. PubMed ID: 16193579
[No Abstract] [Full Text] [Related]
14. AIDS research. Bioethicists assail a celebrated TB/HIV treatment trial.
Cohen J
Science; 2010 May; 328(5980):799-801. PubMed ID: 20466890
[No Abstract] [Full Text] [Related]
15. No impact of rifamycin selection on tuberculosis treatment outcome in HIV coinfected patients.
Singh R; Marshall N; Smith CJ; Reynolds CJ; Breen RA; Bhagani S; Cropley I; Hopkins S; Swaden L; Johnson MA; Lipman MC
AIDS; 2013 Jan; 27(3):481-4. PubMed ID: 23014518
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical reaction in HIV and tuberculosis coinfection.
Wanchu A; Sud A; Bambery P; Singh S
J Assoc Physicians India; 2002 Apr; 50():588-9. PubMed ID: 12164417
[TBL] [Abstract][Full Text] [Related]
17. Use of rifamycins in HIV-infected patients.
Preboth M
Am Fam Physician; 2000 Sep; 62(5):1189-90. PubMed ID: 10997538
[No Abstract] [Full Text] [Related]
18. Tuberculosis: guidelines changed for latent TB treatment.
AIDS Treat News; 2001 Sep; (371):3. PubMed ID: 11668976
[No Abstract] [Full Text] [Related]
19. [Tuberculosis in HIV positive individuals].
Balcells M ME
Rev Chilena Infectol; 2009 Apr; 26(2):126-34. PubMed ID: 19621143
[TBL] [Abstract][Full Text] [Related]
20. Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins.
Bonora S; Mondo A; Trentini L; Calcagno A; Lucchini A; Di Perri G
J Infect; 2008 Jul; 57(1):78-81. PubMed ID: 18550175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
